News Briefing channel feed

News brief­ing: Jef­frey Lei­den to chair Tmu­ni­ty board of di­rec­tors; Op­di­vo wins new ap­proval in ad­vanced RCC

5 years ago

News brief­ing: Eli Lil­ly com­pletes $1B+ Pre­vail buy­out; El­zon­ris ap­proved in Eu­rope for adults

5 years ago

News brief­ing: Five pub­lic biotechs, over 2 days, raise $883M from fresh of­fer­ings; Bel­gian biotech ex­pands Se­ries B fund­ing

5 years ago

News brief­ing: Ve­rastem CMO ex­its two weeks af­ter join­ing com­pa­ny; Ther­mo Fish­er inks $550M M&A deal

5 years ago

News brief­ing: Beam bags a $260M pri­vate place­ment; mi­Ra­gen re­brands to Virid­i­an Ther­a­peu­tics

5 years ago

News brief­ing: Five Prime fi­nal­izes PhI­II plans for gas­tric can­cer; AI di­ag­nos­tics-fo­cused Paige ex­pands staff

5 years ago

News brief­ing: Pre­ci­sion Med­i­cine Group ac­quires cell and gene ther­a­py-fo­cused ser­vices firm Project Far­ma; Roost­er­Bio and Sar­to­rius col­lab on gene ther­a­py man­u­fac­tur­ing

5 years ago

News brief­ing: Mer­ck picks up SHP2 op­tion from Tai­ho-As­tex deal; Taysha ex­pands part­ner­ship with UT South­west­ern

5 years ago

News brief­ing: Ab­b­Vie se­lects first tar­get for Drag­on­fly part­ner­ship; Cog­ni­to nets BDD for Alzheimer's treat­ment de­vice

5 years ago

News brief­ing: Chi-Med en­trusts In­ma­gene with four pre­clin­i­cal pro­grams; Xofluza nets EU ap­proval for flu pre­ven­tion

5 years ago

News brief­ing: Sanofi ponies up more mon­ey to ex­pand pro­tein degra­da­tion col­lab with Nurix; Bio­gen fires shot at No­var­tis in new Spin­raza tri­al

5 years ago

News brief­ing: Pfiz­er kick­starts PhI­II tri­al for DMD gene ther­a­py, out­rac­ing Sarep­ta; Teva's re­for­mu­lat­ed schiz­o­phre­nia shot touts win in late-stage study

5 years ago

News brief­ing: Dew­point scores an­oth­er Big Phar­ma deal, this time with Pfiz­er; Kite joins forces with Ox­ford Bio­Ther­a­peu­tics

5 years ago

News brief­ing: Mar­ius sub­mits NDA for oral hy­pog­o­nadism ther­a­py; Cell­tri­on's bil­lion­aire founder steps down

5 years ago

News brief­ing: 10 years lat­er, teplizum­ab gets a sec­ond shot at an FDA OK; J&J files for ami­van­tam­ab ap­proval in Eu­rope

5 years ago

News brief­ing: In­cyte bankrolls an ear­ly-stage myelofi­bro­sis pair-up with Jakafi; In­no­Care gets Chi­nese ap­proval for lead drug

5 years ago

News brief­ing: Mer­ck buys in­to A2's T cell ther­a­py plat­form; Small Soli­genix re­ports PhI­II fail in head and neck can­cer

5 years ago

News brief­ing: Atom­wise part­ners with Is­raeli in­cu­ba­tor; Bay­er col­lab­o­rates with Ve­r­a­cyte in thy­roid can­cer

5 years ago

News brief­ing: Glax­o­SmithK­line adds to flur­ry of deal­mak­ing; Take­da strikes $322M deal to of­fload a non-core port­fo­lio

5 years ago

News brief­ing: Bio­gen set­tles False Claims Act dis­pute for $22M; Lantern Phar­ma, Johns Hop­kins join forces to ad­vance glioblas­toma ther­a­py

5 years ago

News brief­ing: British psy­che­del­ic in­vest­ment firm launch­es; Irish cell ther­a­py com­pa­ny gains ex­clu­sive li­cense op­tions

5 years ago

News brief­ing: Bob Cough­lin is jump­ing in­to re­al es­tate — in a big way; Keytru­da plus Lenvi­ma posts pos­i­tive PhI­II da­ta in en­dome­tri­al can­cer

5 years ago

News brief­ing: FDA ap­proves oint­ment for pre­can­cer skin le­sions; Take­da nabs pri­or­i­ty re­view for Shire drug

5 years ago

News brief­ing: Arv­inas shares dou­ble on in­ter­im da­ta for two can­cer pro­grams; UK bio­phar­ma snaps up on­col­o­gy CRO

5 years ago
First page Previous page 34353637383940 Next page Last page
A service from the Financial Times